Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

During the past decades, drugs targeting transforming growth factor-β (TGFβ) signaling have received tremendous attention for late-stage cancer treatment since TGFβ signaling has been recognized as a prime driver for tumor progression and metastasis. Nonetheless, in healthy and pre-malignant tissues...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Chen, Jitang, Ding, Ze-yang, Li, Si, Liu, Sha, Xiao, Chen, Li, Zifu, Zhang, Bi-xiang, Chen, Xiao-ping, Yang, Xiangliang
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738904/
https://ncbi.nlm.nih.gov/pubmed/33391538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.51383
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars